USANA Health Sciences

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

Earnings data Q1 2026

USANA Health Sciences reports solid Q1 results amid global challenges

USANA Health Sciences delivered strong Q1 results amidst global challenges, driven by robust demand for health products.
Strategic leadership transition and focus on cost management position the company for sustained growth and operational efficiency.
Opportunities in China market, new market launches, and enhanced customer engagement strategies offer avenues for future expansion.

USANA Health Sciences exceeds Q2 expectations, eyes India expansion

USANA Health Sciences delivered strong Q2 results with a focus on sustainable growth strategies and expansion into new markets. Challenges include tough year-over-year comparisons and cash flow impact from accrued liabilities.

USANA Health Sciences addresses challenges, eyes India expansion for growth

USANA Health Sciences navigated challenges in Q3 2023 with a focus on addressing operational hurdles and driving growth through strategic initiatives. The company's restructuring and expansion into India signal a commitment to long-term success and capitalizing on emerging opportunities.

USANA Health Sciences exceeds Q4 expectations, eyes global growth

USANA Health Sciences delivered strong performance in Q4 2023, driven by growth in Greater China and a solid financial position. While facing challenges such as currency fluctuations and market-specific issues, the company is well-positioned to capitalize on opportunities through strategic initiatives and market tailoring. By focusing on sustainable growth and innovation, USANA aims to further strengthen its market presence and drive profitability.

USANA Health Sciences reports mixed Q1 results, eyes growth strategies

USANA Health Sciences faced mixed results in Q1 2024, with Mainland China driving growth while other markets struggled. The company is addressing challenges through market-specific incentives and focusing on future strategies like product development and localization.

USANA Health Sciences adapts to market challenges with strategic focus

USANA Health Sciences navigated macroeconomic challenges by implementing strategic initiatives and restructuring its commercial team.
The company's focus on product innovation, market expansion into India, and leadership additions signal a commitment to sustainable success.
While facing challenges in market conditions, USANA aims to leverage opportunities like M&A activities and accelerated product development for growth.

USANA Health Sciences adapts strategies to drive growth amid challenges

USANA Health Sciences faced challenges in Q3 with lower-than-expected net sales, particularly in China, but is implementing strategies to boost performance.
The company's strengths in product innovation, streamlined development processes, and strong product lineup position it well for future growth.
Addressing challenges such as decreased average spend and revised guidance presents opportunities for USANA to enhance revenue and market presence.

USANA Health Sciences reports robust Q4 results and eyes growth

USANA Health Sciences delivered strong Q4 results and outlined strategic initiatives for 2025 to drive growth and innovation. The acquisition of Hiya Health and its projected growth present a significant opportunity for USANA in the children's health and wellness market. Challenges include maintaining promotional activities, regional sales performance, and efficient cost management amidst reorganization efforts. Opportunities lie in leveraging the Hiya acquisition, enhancing brand messaging, and driving operational efficiencies for margin expansion and market growth.

USANA Health Sciences reports robust Q1 growth amidst market challenges

USANA Health Sciences (USNA) delivered strong Q1 2025 results driven by growth in net sales and strategic initiatives. The company faces challenges related to tariff impacts, market expansion in India, and maintaining differentiation. Opportunities lie in incentivizing growth in key markets, exploring synergies, and expanding product offerings. Overall, USANA's performance reflects resilience, innovation, and a strategic focus on sustainable growth.

USANA Health Sciences reports robust Q2 performance and eyes Chinese market growth

USANA Health Sciences delivered strong financial performance in Q2, with notable growth in net sales and earnings per share. Strategic initiatives to enhance partnerships, innovate products, and expand globally are driving the company's success. While challenges like a drop in active customers in China exist, USANA remains optimistic about its long-term prospects in the market. The company's focus on operational efficiency, product innovation, and market adaptability positions it well for future growth.

USANA Health Sciences reports strong Q3 performance amidst venture success

USANA Health Sciences delivered a solid performance in Q3 with growth in sales, inventory investments, and successful ventures. While facing challenges in Hiya's growth and cost reduction efforts, the company remains focused on driving engagement and operational efficiency.

USANA Health Sciences reports solid Q4 performance and eyes growth

USANA Health Sciences' Q4 2025 call highlighted a strong performance and strategic focus on growth drivers like product innovation and technology. The company's strengths in brand positioning, customer experience enhancement, and scientific integrity position it well for future success. While facing challenges in workforce impact and technology integration, USANA Health Sciences has opportunities to drive growth through innovation and omnichannel expansion.